tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics (DE:2LB)
NASDAQ:2LB

Compare Iovance Biotherapeutics (2LB) vs. Competitors

Compare
17 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Iovance Biotherapeutics
€3.17
€1.31B
-3.33%
6 Buy
3 Hold
1 Sell
Moderate Buy
KalVista Pharmaceuticals
$17.00
$859.29M
41.67%
8 Buy
0 Hold
0 Sell
Strong Buy
Vir Biotechnology
$9.10
$1.45B
32.46%
8 Buy
0 Hold
0 Sell
Strong Buy
Immatics
$9.43
$1.26B
77.92%
6 Buy
0 Hold
0 Sell
Strong Buy
Nuvation Bio
$4.22
$1.47B
-14.96
115.31%
7 Buy
1 Hold
0 Sell
Strong Buy
Amylyx Pharmaceuticals Inc
$13.81
$1.53B
-7.89
270.24%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2LB
Iovance Biotherapeutics
3.17
-0.12
-3.68%
KALV
KalVista Pharmaceuticals
17.00
4.75
38.78%
VIR
Vir Biotechnology
9.10
1.90
26.39%
IMTX
Immatics
9.43
4.43
88.60%
NUVB
Nuvation Bio
4.22
2.26
115.31%
AMLX
Amylyx Pharmaceuticals Inc
13.81
10.03
265.34%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts